We Have Unlocked The Potential Of Data In The DMTA Cycle

In this progressive world, where technology is leading the future, AstraZeneca has partnered with Nasscom for incubating tech start-ups in the healthcare sector. The objective is to enable collaboration across R&D, technology, government and education. Siva Padmanabhan, MD & Head of Global Technology Center, AstraZeneca India talks about the role of AI and Machine Learning in the life sciences sector and key initiatives taken by AstraZeneca with Usha Sharma

- Usha Sharma

Tell us more about AstraZenca's partnership with Nasscom

AstraZeneca’s iDREAM initiative partnered with Nasscom IoT Centre of Excellence in November 2018 to accelerate innovative technologies that can provide affordable solutions for early screening and management of Non-Communicable Diseases (NCDs). The partnership, christened Unnati Healthcare Innovation Challenge, focuses on disease management, reduction of healthcare costs and early- and remote screening of diseases by providing expertise and funds. Unnati is based on the India Sweden Joint Declaration on Innovation Partnership for Sustainable Future.

How can this partnership drive scientific innovation in domestic market and promote quality manufacturing?

The partnership aims to strengthen India’s position in the global ecosystem of scientific innovation. AstraZeneca will support Nasscom in incubating tech start-ups in the healthcare sector, enabling collaboration across R&D, technology, government and education. It also serves as a platform for best practice sharing.

How can AI, Machine Learning drive growth for AstraZeneca?